{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"technology_type":["Illumina HiSeq 2000"],"study_type":["Cancer Genomics"],"full_dataset_link":["https://ega-archive.org/studies/EGAS00001000251"],"host":["EGA"],"description":["EGA study EGAS00001000251"],"dataset_title":["Melanoma-Til Study RNAseq"],"repository":["EGA"],"category":["restricted"],"name_synonyms":["melanoma (disease), malignant melanoma, study., Melanomas, Melanoma, Malignant Melanomas, melanoma, Malignant, malignant, Malignant Melanoma, Naevocarcinoma"],"description_synonyms":["Antigenic Determinants, other disease, Thymus-Dependent Lymphocytes, human being, Product, Blood, Neoplasms, developmental stage, infiltrating, Benign Neoplasm, T-Lymphocyte, Tumor, Antigenic Specificity, Malignant, Human, Mutations, Determinant, Homo sapiens, diseases, T Lymphocyte, Pharmaceutical Product, disease or disorder, diseases and disorders, Blood Corpuscle, immature T cell, Man, Drugs, study, human disease, Man (Taxonomy), Genomes, Malignancy, T-Cells, Antigenic, T, non-neoplastic, Neoplasias, T Cells, drugs, Pharmaceuticals., malignant neoplasm, medicine, Pharmaceutical, mature T cell, disorder, Homo sapiens disease, stage, Lymphoid, Malignancies, Preparation, T Lymphocytes, Thymus Dependent Lymphocytes, Lymphocyte, Cancer, Tumors, Products, Epitope, Malignant Neoplasm, Modern, disorders, Malignant Melanomas, medical condition, Medications, Cell, Melanomas, Melanoma, MT, Benign, T-Cell, Malignant Melanoma, Diseases, Neoplasm, Corpuscles, condition, Lymphoid Cell, Pharmaceutic, Determinants, T lymphocyte, Lymphoid Cells, Antigenic Determinant, Blood Cell, T-cell, primary cancer, Pharmaceutic Preparations, Thymus-Dependent, Specificity, Benign Neoplasms, Lymphocytes, whole genome, Cancers, T-lymphocyte, malignant tumor, human, Thymus-Dependent Lymphocyte, Malignant Neoplasms, Drug, disease, Corpuscle, Preparations, T cell, Modern Man, Cells, T Cell, Blood Corpuscles, other neoplasm, Pharmaceutical Products, Neoplasia, humans, Pharmaceutical Preparation"],"additional_accession":[]},"is_claimable":false,"name":"Melanoma Til Study RNAseq","description":"In this study, mutations present in a series of human melanomas (stage IV disease) will be determined, using autologous blood cells to obtain a reference genome. From each of the samples that are analyzed, tumour-infiltrating T lymphocytes have also been isolated. This offers a unique opportunity to determine which (fraction of) mutations in human cancer leads to epitopes that are recognized by T cells. The resulting information is likely to be of value to understand how T cell activating drugs exert their action.","dates":{"updated":"2017-07-26 15:39:25"},"accession":"EGAS00001000251","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAD00001000325","EGAC00001000000"]}}